Analyst firms · H.C. Wainwright · ABEO
H.C. Wainwright ABEO price target and rating history
Abeona Therapeutics Inc. (ABEO) · Health Care
H.C. Wainwright rates Abeona Therapeutics Inc. (ABEO) Buy with a $15 price target, as of its latest action on Jul 3, 2024. It has published 3 rating actions on ABEO since July 2021, including 0 upgrades and 0 downgrades.
- Current rating
- Buy
- Price target
- $15
- Median target, all firms
- Too few
- Actions on ABEO
- 3
H.C. Wainwright price target on ABEO
Every H.C. Wainwright rating on ABEO
- Jul 3, 2024
- Nov 29, 2021
- Jul 19, 2021
Questions about H.C. Wainwright and ABEO
- What is H.C. Wainwright's price target for ABEO?
- H.C. Wainwright's latest stated price target for Abeona Therapeutics Inc. (ABEO) is $15, from its action on Jul 3, 2024.
- What is H.C. Wainwright's rating on ABEO?
- H.C. Wainwright rates ABEO Buy, a bullish rating, as of Jul 3, 2024.
- When did H.C. Wainwright last change its view on ABEO?
- On Jul 3, 2024, H.C. Wainwright starts coverage at Buy, price target $15.
All H.C. Wainwright ratingsABEO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.